NCT06375369 Digital Health Pathway for Children With Medical Complexity Requiring Tracheostomy
| NCT ID | NCT06375369 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Alberta |
| Condition | Tracheostomy |
| Study Type | INTERVENTIONAL |
| Enrollment | 180 participants |
| Start Date | 2024-09-01 |
| Primary Completion | 2027-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 180 participants in total. It began in 2024-09-01 with a primary completion date of 2027-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The DECIDE-T project is developing a standardized clinical pathway specifically for pediatric patients who require tracheostomy with or without long-term ventilation (tracheostomy/LTV). These patients represent a small portion of Alberta's population but account for over 50% of pediatric patients hospitalized for more than 180 days. The pathway will include a hospital-to-home directive that incorporates digital health solutions to provide support to families, caregivers, and healthcare professionals. Digital supports will include a Connect Care pathway, resources for informed decision-making, educational modules, high-fidelity simulations for family and caregiver education, an online parental resource center, and access to peer support within the hospital and community, as well as a post-discharge telehealth program. The goal of the DECIDE-T project is to reduce hospital stays and associated costs for children requiring tracheostomy/LTV, as well as to decrease mental distress and burnout experienced by their caregivers and families.
Eligibility Criteria
Inclusion Criteria: * Age \< 18 years * First tracheostomy placement Exclusion Criteria: \-
Contact & Investigator
Maria Castro Codesal, MD, PhD
PRINCIPAL INVESTIGATOR
University of Alberta
Frequently Asked Questions
Who can join the NCT06375369 clinical trial?
This trial is open to participants of all sexes, up to 18 Years, studying Tracheostomy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06375369 currently recruiting?
Yes, NCT06375369 is actively recruiting participants. Contact the research team at castroco@ualberta.ca for enrollment information.
Where is the NCT06375369 trial being conducted?
This trial is being conducted at Calgary, Canada, Edmonton, Canada.
Who is sponsoring the NCT06375369 clinical trial?
NCT06375369 is sponsored by University of Alberta. The principal investigator is Maria Castro Codesal, MD, PhD at University of Alberta. The trial plans to enroll 180 participants.